The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Image Source: Zacks Investment Research Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic ...

May 3, 2021 /PRNewswire/ — Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray ... on its CyberKnife S7 and Radixact ...

Accuray Incorporated (NASDAQ: ARAY) announced today the initiation of CyberKnife® S7™ System medical professional training at its education center located within the newly opened Genolier ...

The company has a P/S ratio of 0.5 compared with the industry’s 3.1. Potential in Radiosurgery Market: Accuray’s CyberKnife System is a robotic radiosurgery system capable of treating tumors ...